In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta

Diabetes

Volumn 57, Issue 2, 2008, Pages 476-483

  Boden, Guenther ^a,b   Song, Weiwei ^a   Pashko, Laura ^a   Kresge, Karen ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; FATTY ACID; GELATINASE A; GELATINASE B; GLYCEROL; HEPARIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LIPID; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; HYPERINSULINEMIA; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; DRUG EFFECT; ENZYMOLOGY; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INDWELLING CATHETER; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; AORTA; CATHETERS, INDWELLING; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN; MALE; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 40749101596     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1261     Document Type: Article

References (51)

1. Bjorntorp P, Bergman H, Varnauskas E: Plasma free fatty acid turnover in obesity. Acta Med Scand 185:351-356, 1969
2. Reaven GM, Hollenbeck C, Jenk C-Y, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1998
3. Stern MP: Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44:369-374, 1995
4. Ross R: The pathogenesis of atherosclerosis: a perspective for the 90s.Nature 362:801-809, 1993
5. Reaven GM: The role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. Hennekens CH: Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 97:1095-1102, 1998
7. Newby AC: Dual role of matrix metalloproteinases (Matrixins) in intimal thickening of atherosclerotic plaque rupture. Physiol Rev 85:1-31, 2005
8. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545, 1994
9. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994
10. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, Borst C: Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteinases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150:245-253, 2000
11. Goodall S, Porter KE, Bell PR, Thompson MM: Enhanced invasive properties exhibited by smooth muscle cells are associated with elevated production of MMP-2 in patients with aortic aneurysms. Eur J Vasc Endocvasc Surg 24:72-80, 2002
12. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625-632, 2002
13. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smeija M, Hafner G, Meyer J, Cambine F, Tiret L: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585, 2003
14. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
15. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N: Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kB pathway in rat liver. Diabetes 54:3458-3465, 2005
16. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metallo-proteinases: structure, function and biochemistry. Circ Res 92:827-839, 2003
17. Fischoeder A, Meyborg H, Steibenz D, Fleck E, Graf K, Stawowy P: Insulin augments matrix metalloproteinase-9 expression in monocytes. Cardio-vasc Res 73:841-848, 2007
18. Lee MPS, Sweeney G: Insulin increases gelatinase activity in rat glomerular mesangial cells via ERK- and PI-3 kinase-dependent signalling. Diabetes Obes Metab 8:281-288, 2005
19. Dandona P, Aljada A, Mohanty P, Granim H, Bandyopadhyay A, Chaudhuri A: Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26:3310-3314, 2003
20. Richardson DK, Kashyap S, Baja M, Cusi K, Mandarino SJ, Finlayson J, DeFronzo RA, Jenkinson CP, Mandarino LJ: Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 280:10290-10297, 2005
21. Chen X, Ruiz J, Boden G: Release, oxidation, and reesterification of fatty acids from infused triglycerides: effect of heparin. Metabolism 44:1590-1595, 1995
22. Kenagy RD, Nikkari ST, Weigus HG, Clowes AW: Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelati-nases, and collagenase) in primate 0arterial smooth muscle cells. J Clin Invest 93:1987-1993, 1994
23. Gogly B, Dridi M, Hornebeck W, Bonnefoix M, Godeau G, Pellat B: Effect of heparin on the production of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human dermal fibroblasts. Cell Biol Int 23:203-209, 1999
24. Risinger GM, Hunt TS, Updike DL, Bullen EC, Howard EW: Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem 281:25915-25925, 2006
25. Saltiel RA. Kahn CR: Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799-806, 2001
26. Cho A, Graves J, Reidy MA: Mitogen-activated protein kinases mediate matrix metallo-proteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532, 2000
27. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9:726-735,1995
28. Lehman JA, Gomez-Cambronero J: Molecular crosstalk between p70S6k and MAPK cell signaling pathways. Biochem Biophys Res Commun 293:473-469, 2002
29. Zhang H, Shi X, Hampong M, Blanis L, Pelech S: Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J Biol Chem 276:6905-6908, 2001
30. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 420:333-336, 2002
31. 2-terminal kinase/stress-activated protein kinase by insulin. Biochem 35:8769 -8775, 1996
32. Malhi H, Bronk SF, Werneburg NW, Gores GJ: Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281:12093-12101, 2006
33. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J: Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 18:2024-2034, 2004
34. Ozcan U, Cao Q, Yilmaz E, Lee A-H, Iwakoshi NN, Ozdelen E, Tuncman G, Gorun C, Glimcher LH, Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461,2004
35. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M: Activation of stress-activated kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16:295-305, 1997
36. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145, 2001.
37. Collins QF, Xiong Y, Lupo EG, Liu H-Y, Cao W: p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepa-tocytes. J Biol Chem 281:24336-24344, 2006
38. Raingeaud J, Gupta S, Rogers JS, Dickents M, Han J, Ulevitch RJ, Davis RJ:Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426, 1995
39. Miller TA, LeBrasseur NK, Cote GM, Trucillo MP, Pimentel DR, Ido Y, Ruderman NB, Sawyer DB: Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun 336:309-315,2005
40. Dersch K, Ichijo J, Bhakdi S, Husmann M: Fatty acids liberated from low-density lipoprotein trigger endothelial apoptosis via mitogen-activated protein kinases. Cell Death Differ 12:1107-1114, 2005
41. Zarubin T, Han J: Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18, 2005
42. Jiang ZY, Lin Y-W, Clemont A, Feener EP, Hein DK, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104:447-457, 1999
43. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediate signaling in human muscle. J Clin Invest 105:11-20, 2000
44. Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011, 2002
45. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C8 and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
46. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025, 2006
47. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G: Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR 120. Nat Med 11:90-94, 2005
48. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M: Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173-176, 2003
49. Paz K, Hemi R, Leroith D, Karasik A, Elhanany E, Kanety H, Zick Y: A molecular basis for insulin resistance. Elevated serine/threonine phos-phorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911-29918, 1997
50. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119, 2005
51. Shashkin PN, Jain N, Miller YI, Rissing BA, Hua Y, Keller SR, Vandenhoff GE, Nadler JL, McIntyre TM: Insulin and glucose play a role in foam cell formation and function. Cardiovas Diabetology 5:5-13, 2006